AstraZeneca, NHS, Lundbeck to Discuss AI's Impact on Drug Discovery at AI LIVE

AI is transforming drug discovery and development by accelerating scientific discovery, improving clinical trial success, and optimizing drug development pipelines. Senior leaders from AstraZeneca, the NHS, and Lundbeck will discuss how AI is revolutionizing the industry at the AI LIVE: The London Summit. The panel will examine how AI is accelerating drug development, improving clinical trial success, and optimizing drug development pipelines. Speakers include Tom Diethe, Executive Director and Head of AstraZeneca's Centre for Artificial Intelligence, and Matea Deliu, Chief Clinical Information Officer at Bromley Healthcare/Guy's & St. Thomas' NHS Foundation Trust.